DRTV campaign includes powerful customer review of ETST’s CBD products
DORAL, Florida, Nov. 13, 2018 (GLOBE NEWSWIRE) -- Earth Science Tech, Inc. (OTCQB: ETST) (“ETST" or the “Company"), an innovative biotech company focused on the cannabidiol (CBD), nutraceutical and pharmaceutical fields, medical devices, and research and development, today announces that it has commenced filming of its direct response television (DRTV) media campaign with mega-entrepreneur Kevin Harrington’s award-winning As Seen On TV production company. The film will include an interview with a customer whose life was positively changed by ETST’s High Grade Full Spectrum Cannabinoids.
As announced in September, ETST signed an agreement for an As Seen On TV campaign that will include a 60-second DRTV commercial spot to be aired 300 times within 10 selected regions and selected networks; a 15-second promotional video to be used for digital and social media purposes; a featured placement on the website for 12 months; complete licensing rights to the commercial spot and promotional video; and permission to use the world-famous As Seen On TV logo on ETST’s products.
Production of the campaign begins in Ft. Lauderdale, Florida, where Rhoda Friedman shares how ETST’s CBD products have provided relief from pain she has endured for 31 years.
“I've been on ETST’s CBD since April 2017. I am 73 years old and I have been in excruciating pain from approximately 1987. Until I started CBD, I was not able to walk steps or stand for more than five minutes without severe pain in my lower lumbar, which I had surgery on eight years ago - and the pain just increased. I was on 29 pills a day and I am happy to say that five days after I began CBD and ever since I have only been on a blood thinner. I have been able to walk, go up and down the steps, dance, and move about in ways I never thought I would ever be able to do again. I have trichotillomania, which is pulling out of the hair, but I have not been affected by it since I've been on the CBD. I had a fatty enlarged liver from hepatitis C … three months after I started taking CBD my liver was normal size with no fat - it returned to normal. I also suffered since 1990 with post-traumatic stress disorder where my hands were shaking to the point I could barely feed myself. The shaking totally stopped within the first day of the CBD. I also suffered from obsessive compulsive disorder to the point where it disrupted a lot of my activities. I no longer suffer from that. I had anxiety attacks … I no longer suffer from that. In short, my life is back to what it was when I was in my 40s and suffered from none of it.”
The film will air nationwide in the first quarter of 2019, and will also be shared via social media for optimal brand awareness. ETST owns the rights to the material, as well as how it will be disseminated and utilized in retail locations.
ETST president, director and Chairman Nickolas S. Tabraue stated, “I am excited that we have started production and that we have Rhoda Friedman to share her amazing story with the world. Rhoda is an amazing woman. Everyone with whom she shares her life-changing experience with our products can see and feel her passion. Once production is complete, I will share updates and share the material that is being put together by Kevin Harrington’s amazing team.”
About Earth Science Tech, Inc. (ETST)
Earth Science Tech, Inc. (“ETST”) offers the highest purity and quality high-grade full spectrum cannabinoid oil on the market. There are positive results in studies on breast cancer and immune cells through the University of Central Oklahoma, in addition to studies through DV Biologics that prove the Company’s CBD oil formulation lowers cortisol and functions as a neuro-protectant, with positive result case studies through key health organizations. ETST formulates, markets and distributes the CBD oil used for its studies to the public, offering the most effective quality of CBD on the market.
To learn more, please visit: www.EarthScienceTech.com
ETST currently has four wholly owned subsidiaries focused on developing its role as a world leader in the CBD space and expanding its work in the pharmaceutical and medical device sectors:
Earth Science Pharmaceutical, Inc.
Earth Science Pharmaceutical ("ESP") is a wholly owned subsidiary of Earth Science Tech), committed to the development of low cost, noninvasive diagnostic tools, medical devices, testing processes and vaccines for sexually transmitted infections and/or diseases. ESP's CEO and chief science officer, Dr. Michel Aubé, is leading the company’s research and development efforts. The company’s first medical device, MSN-2, is a home kit designed for the detection of STIs, such as chlamydia, from a self-obtained gynecological specimen. ESP is working to develop and bring to market medical devices and vaccines that meet the specific needs of women. To learn more please visit: www.EarthSciencePharmaceutical.com
Cannabis Therapeutics, Inc.
Cannabis Therapeutics (“CTI”) is a wholly owned subsidiary of Earth Science TechTich i poised to take a leadership role in the development of new, leading-edge cannabinoid-based pharmaceutical and nutraceutical products. CTI is invested in research and development to explore and harness the medicinal power of cannabidiol. The company holds three provisional application patents for a CBD product that is focused on developing treatments for breast and ovarian cancers, as well as two generic CBD based pharmaceutical drugs. To learn more please visit: www.CannabisThera.com
KannaBidioiD, Inc.
KannaBidioiD (“KBD”) is a wholly owned subsidiary of Earth Science TechB that provides a wide variety of products geared toward the recreational space of cannabis. KBD’s unique Kanna and CBD formulation is sold and distributed in CBD-infused vapes/e-liquids products. Kanna and CBD synergistically enhance one another, providing optimal relaxation, an uplifting sensation, enhanced focus and the added benefit of assisting with nicotine reduction therapy. To learn more please visit: www.KannaBidioiDInc.com
Earth Science Foundation, Inc.
Earth Science Foundation. (“ESF”) is a wholly owned subsidiary of Earth Science Tech. ESF is in the process of becoming a nonprofit organization to accept grants and donations to conduct further studies and help donate Earth Science Tech's effective CBD products to those in need. To learn more please visit: www.ETSTFoundtion.org
SAFE HARBOR ACT: Forward-Looking Statements are included within the meaning of Section 27A of the Securities Act of 1933, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements regarding our expected future financial position, results of operations, cash flows, financing plans, business strategy, products and services, competitive positions, growth opportunities, plans and objectives of management for future operations, including words such as "anticipate," "if," "believe," "plan," "estimate," "expect," "intend," "may," "could," "should," "will," and other similar expressions are forward-looking statements and involve risks, uncertainties and contingencies, many of which are beyond our control, which may cause actual results, performance, or achievements to differ materially from anticipated results, performance, or achievements. We are under no obligation to (and expressly disclaim any such obligation to) update or alter our forward-looking statements, whether as a result of new information, future events or otherwise.
Company Contact:
www.EarthScienceTech.com
Nickolas S. Tabraue
President, Director & Chairman
305.615.2118 Office
Corporate Communications Contact:
NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com